Gaurav Gupta

Direttore/Membro del Consiglio presso NewAmsterdam Pharma BV

Consumer Services

Health Technology

Finance

Profilo

Gaurav Gupta is currently a Non-Executive Director at NewAmsterdam Pharma BV.
Previously, he worked as a Director at NewAmsterdam Pharma Co. NV and as an Associate at OrbiMed Advisors Private Equity.
He received undergraduate, graduate, and doctorate degrees from The Johns Hopkins University and a doctorate degree from Stanford University School of Medicine.

Posizioni attive di Gaurav Gupta

Società	Posizione	Inizio
NewAmsterdam Pharma BV NewAmsterdam Pharma BV Pharmaceuticals: MajorHealth Technology NewAmsterdam Pharma BV develops novel drugs to treat dyslipidemia. It operates as a biotechnology company and develops anti-dyslipidemic compounds in cardiovascular disease indications. The firm's product DEZ-001 develops a potent cholesteryl ester transfer protein inhibitor that has shown a decrease of low-density lipoprotein levels, and an increase of high-density lipoprotein levels. The company was founded by John J. P. Kastelein in 2012 and is headquartered in Naarden, the Netherlands.	Direttore/Membro del Consiglio	-

Tutte le posizioni attive di Gaurav Gupta

Precedenti posizioni note di Gaurav Gupta

Società	Posizione	Fine
FRAZIER LIFESCIENCES ACQUISITION CORPORATION	Direttore/Membro del Consiglio	-
OrbiMed Advisors Private Equity OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London.	Analista di Private Equity	-

Vedi nel dettaglio l'esperienza di Gaurav Gupta

Formazione di Gaurav Gupta

Stanford University School of Medicine	Doctorate Degree
The Johns Hopkins University	Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Gaurav Gupta

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
FRAZIER LIFESCIENCES ACQUISITION CORPORATION	Health Technology

Aziende private	2
OrbiMed Advisors Private Equity OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London.	Finance
NewAmsterdam Pharma BV NewAmsterdam Pharma BV Pharmaceuticals: MajorHealth Technology NewAmsterdam Pharma BV develops novel drugs to treat dyslipidemia. It operates as a biotechnology company and develops anti-dyslipidemic compounds in cardiovascular disease indications. The firm's product DEZ-001 develops a potent cholesteryl ester transfer protein inhibitor that has shown a decrease of low-density lipoprotein levels, and an increase of high-density lipoprotein levels. The company was founded by John J. P. Kastelein in 2012 and is headquartered in Naarden, the Netherlands.	Health Technology